Biotech teams are operating in an environment defined by uncertainty—tighter funding, increased scrutiny, and growing expectations for speed, compliance, and control. In that context, operational decisions matter more than ever.
Prendio’s 2025 Year in Review / 2026 Outlook shares how hundreds of biotech organizations are navigating these pressures. Inside, you’ll find real data on time saved, costs reduced, and how procurement technology and services can scale without adding complexity or headcount.
The report highlights key product innovations, measurable customer outcomes, and our vision for 2026—focused on deeper intelligence, unified procurement and payments, and continued investment in the people and systems that support science.
Whether you’re building infrastructure for growth or refining operations to extend runway, this report offers a clear look at what’s working across the biotech community and what comes next.